Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZTC -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (505)	2/2/1998 8:30:00 PM
From: Resry	Respond to of 752

GZTC has a line of credit from GENZ and the Bank of Boston. Also, their contract research helps pay for their transgenic research. This is one of the reasons I own the stock. Not a typical biotech company that constanly burns $$.

To: Andrew H who wrote (505)	2/2/1998 9:24:00 PM
From: Sleepman	Read Replies (3) \| Respond to of 752

I agree with everything that you said. I am not sure if my advisor really understands this company. I am not too good with the financial stuff which is a reason that I rely on this guy. I currently have a small position in GENZ, and am fascinated by GZTC. I think that it could be a real winner, but really do not know at what point I should get in. Anyway, right now, I have so much tied up in Ligand right now that I cannot afford to expand my portfolio. Thnaks for you valued opinion. Dan